Rocket Lab Corporation RKLB
73.95
0.34
0.46%
as of 25 Sep
- Market cap
- $44.8B
- P/E
- 0.0×
Follow RKLB
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
83.22 | 57.21 | 61.51 | 45.68 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(761.31) | (772.49) | (573.67) | (1,076.87) | |
P/B ratio |
18.33 | 17.17 | 21.50 | 19.77 | |
Price to Tangible BV |
22.28 | 21.19 | 28.67 | 30.47 | |
EV/Sales |
80.29 | 55.28 | 60.13 | 44.69 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(277.58) | (232.43) | (218.63) | (239.75) | |
EV/FCF |
(166.82) | (119.19) | (112.59) | (107.58) | |
Quick Ratio |
4.57 | 3.62 | 3.16 | 2.50 | |
Current Ratio |
5.48 | 4.47 | 4.08 | 3.18 | |
Net Debt/EBITDA |
62.23 | 32.57 | 23.74 | 11.79 | |
Debt/Assets |
0.70% | 1.88% | 7.26% | 19.36% | |
Debt/Equity |
0.01 | 0.02 | 0.10 | 0.34 | |
Asset Turnover |
0.27 | 0.33 | 0.34 | 0.33 | |
Operating CF/Net income |
1.71 | 1.12 | 1.22 | 1.29 | |
Capex/Depreciation |
(1.24) | (1.74) | (3.24) | (3.63) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
35.22% | 40.19% | 43.85% | 45.59% | |
Selling, General and Administrative Expense of Revenue |
25.49% | 25.93% | 22.54% | 29.40% | |
Intangible Assets out of Total Assets |
0.15 | 0.15 | 0.19 | 0.20 | |
Share Based Compensation of Revenue |
8.36% | 14.03% | 10.13% | 10.14% | |
Graham Net Nets |
0.03 | 0.03 | 0.02 | 0.01 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.27%) | (0.50%) | (0.53%) | (0.79%) | |
Free Cash Flow Yield |
(0.58%) | (0.81%) | (0.87%) | (0.91%) | |
Revenue per Share |
0.37 | 0.33 | 0.34 | 0.29 | |
Operating CF per Share |
(0.13) | (0.08) | (0.12) | (0.04) | |
Capex per Share |
(0.04) | (0.04) | (0.09) | (0.09) | |
Free Cash Flow per Share |
(0.17) | (0.13) | (0.22) | (0.13) | |
Cash per Share |
3.66 | 2.28 | 1.92 | 1.85 | |
Shareholders Equity per Share |
5.55 | 3.74 | 3.24 | 2.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.55 | 3.74 | 3.24 | 2.42 | |
Free Cash Flow |
(110.12) | (76.68) | (114.18) | (69.18) | |
Working Capital |
2,367.56 | 1,398.02 | 1,031.07 | 901.97 | |
Capital Expenditures |
(26.05) | (26.35) | (49.65) | (45.66) | |
Net Current Asset Value |
2,200.54 | 1,244.79 | 762.92 | 376.01 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.11 | 0.13 | 0.28 | 0.29 | |
Net Profit Margin |
(21.04%) | (22.47%) | (29.46%) | (11.77%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
87.34 | 57.18 | 37.72 | 40.62 | |
Average Payables |
72.76 | 66.66 | 62.88 | 51.83 | |
Average Inventory |
198.58 | 154.37 | 138.74 | 129.72 | |
Average Assets |
2,870.30 | 2,037.46 | 1,754.41 | 1,687.21 | |
Average Common Equity |
2,090.31 | 1,347.83 | 1,052.15 | 850.41 |
Columns are period end dates